To investigate the role o f distance between two opioid peptide pharmacophores on binding activities to delta, mu and kappa receptor in vitro, a number o f new dimeric enkephalin analogues were synthesized in which two identical tetrapeptides: Tyr-D-Ala-Gly-Phe were connected together at their C-termini by a,&>-diamino-a,a>-dideoxyalditols. The length of the hydrophilic spacer ( 3 -6 carbons) did not affect the affinities for delta receptors, whereas the affinities for mu and kappa receptors were dependent on the length as well as the configura tion of the spacer. The analogues had high affinities, and som e of them possessed moderate delta selectivity.
Introduction
In the developm ent of chemistry for enkephalin analogues, it was found [1] [2] [3] that some glycosy lated opioid peptides showed higher biological ac tivity than the parent peptide compound itself. It can be assumed that the incorporation of sugar moieties in the enkephalin sequence could alter conform ational properties, enzymatic stability and the affinity of the molecule toward opioid receptors.
On the other hand, a num ber of laboratories [4] [5] [6] [7] introduced a new class of opioid analogues which contained two peptide pharmacophores in one molecule. In most of the synthesized dimeric enkephalin analogues, diaminoalkyl chains were used as spacers connecting two peptide fragments at the C-termini.
In light of the above, we have proposed [8, 9 ] the use of hydrophilic sugar derived multihydroxyl spacers for bridging two tetrapeptides. The re sulted dimeric analogues possessed the following structures:
* Reprint requests to Dr. Janusz St^piriski.
Tyr-D-Ala-Gly-Phe-NH-CH2 I (CHOH )" I Tyr-D-Ala-Gly-Phe-NH-CH2
where n = 1, 2 or 4. The tetrapeptide Tyr-D-AlaGly-Phe, the minimum enkephalin-related se quence necessary for high affinity for opioid re ceptors, was used as an opioid pharmacophore. Various configurations of the multihydroxyl link ers were used, and our previous studies [8, 9] de m onstrated that both the length and the configura tion of the bridge were im portant factors in receptor potency and selectivity.
In the present study we report the syntheses of new analogues within this series. The five-carbon spacers or bridges bearing three hydroxyl groups (n -3) of different configuration have been em ployed for linking two tetrapeptide fragments. In addition we present one analogue with longer spacer (n = 4) with D-m anno configuration and one reference com pound of "m onom eric" nature having tetrapeptide term inated with ethanolamide. The effect of length as well as configuration of a spacer on selectivity of a bivalent opioid li gand was of interest in this study.
Experim ental
The 13C NM R spectra were obtained with a Jeol FX90Q spectrometer. IR spectra were recorded 0 9 3 2 -0 7 7 6 /9 5 /0 9 0 0 -1 3 2 9 $06.00 © 1995 V erlag d e r Z e itsc h rift fü r N a tu rfo rs c h u n g . A ll rig h ts re se rv e d . D with a UR-20 Zeiss spectrophotom eter. Optical rotations were m easured with a Perkin-Elm er 241 polarimeter. The liquid matrix secondary ions mass spectrometry (LSIMS) was perform ed on an AMD-604 Intectra G m bH spectrometer. Analyti cal HPLC analyses were perform ed on a SpectraPhysics SP 8800 liquid chrom atograph, utilizing an analytical Supelco LC-18-T (25 cm with a 2 cm guard) reversed phase column. The solvent system was buffer A (0.01 M KH 2P 0 4, pH 3.0) and buffer B (50% buffer A / 50% acetonitrile, v/v). The lin ear gradient was 40-100% B in 20 min, the flow rate 2.0 ml/min, and monitoring was perform ed at 210 nm. [10] starting from the appropriate aldoses: D-ribose, D-xylose and D-mannose, respectively. Analytical data, which were in good accord with the reported ones [10] , and in addition IR and 13C NM R spectra confirmed the proposed structures. (10) were pre pared according to the scheme depicted in Fig. 1 . Experim ental details for the syntheses were simi larly described elsewhere [9] , The final crude pro ducts were purified on a Sephadex G 25 column using «-butanol -acetic acid -water (4:1:5, upper phase) as solvent. A ppropriate fractions were pooled and lyophilized. Portions of each com pound (a few mg) were repurified by sem iprepara tive HPLC using a Supelco LC-18-DB reverse phase column with linear gradients of buffer A (0.03 M ammonium acetate, pH 5.0) and buffer B (33% buffer A / 67% acetonitrile, v/v) and m oni toring at 230 or 260 nm. Collected fractions were lyophilized twice to obtain fine white powdery fi nal products. The homogeneity and identity of the compounds were checked by analytical HPLC, LSIMS and TLC. Thin layer chrom atography (TLC) was performed on silica gel (Kieselgel G, Merck) using the following solvent systems (v/v): (A) isopropanol -triethylamine -w ater = 7:1:2, (B) «-butanol -acetic acid -water = 4:1:2, (C) n-butanol -pyridine -acetic acid -water = 4:1:1:1. The prepared analogues gave correct amino acid analyses. Analytical data for com pounds 6 -1 0 are shown in Table I . 6.
Chemical Synthesis

2-(Tyrosyl-D-alanyl-glycyl-phenylalanylam -
ido)-ethanol (11) was obtained utilizing ethanolamine as a starting m aterial and using the same strategy as shown in Fig. 1 . Purification procedures were the same as described above. Analytical data for the compound are shown also in Table I .
Receptor Binding Assays
Brains were dissected from decapitated male Hartley guinea pigs. Brain membranes preparation and receptor binding assays were perform ed as de scribed previously [12, 13] Table II . 
[ Y -D A -G -F -N H -C H^-C H O H -]2C H
Results and Discussion
The reaction pathways leading to the synthesis of compounds 6 -1 0 are shown in Fig. 1 . The pre sented route followed exactly our previously re ported strategy [9] . The presence of free hydroxyl groups in multihydroxyl substrates (1 -5 ) and con secutive intermediates, as well as the one on tyro sine moiety did not interfere during coupling reac tions. Compound 11 was prepared in a similar m anner starting from ethanolam ine and equimolar peptide intermediates. The crude products (6 -1 1 ) were purified by gel filtration over Sephadex G-25 and then, for analytical and receptor binding assay purposes, samples of each compound were obtained by semipreparative HPLC. Analytical data for the final enkephalin analogues are shown in Table I . The analytical HPLC was the ultimate criterion for purity of the compounds. Single peaks were detected for all 6 -1 1 final products. F urther more, the obtained mass spectra (LSIMS) gave proper molecular ions with predicted isotopic pat terns. Thus, the dimeric structures of compounds 6 -1 0 were confirmed.
The newly synthesized enkephalin analogues were tested for receptor binding to d, /x and x re ceptors in guinea pig brain homogenates by the m ethodology reported elsewhere [14] . The bioas say conditions were the same as used previously for characterization of other dimeric analogues [8, 9, 14] . The obtained K, values for dimeric com pounds 6 -1 0 are presented in Table II and com pared with the results for the earlier prepared di meric hydrophilic analogues (B -F ), as well as for other referable compounds, including "mono m eric" analogue 11.
Delta affinity and selectivity. As presented in Ta ble II, analogues with multihydroxyl spacers (ex cept of only com pound B, which bore one hy droxyl group) possessed similar d affinity comparable to that for d ynorphin(l-13) but lower than that for DA D LE. We observed no marked dependence of the affinity on the length of the hydrophilic linker and only minor effects of the various configurations of the spacers. Thus, we conclude that none of the compounds acts as a real bivalent opioid, i.e. binding simultaneously to two distinct but closely clustered < 3 receptors. It is pos sible that the distance between two peptide ligands in our analogues is too short to bridge two (3 recep tor sites. It is in accord with earlier Shimohigashi et al. [4] observations that the optimum distance for a spacer chain was 10-12 carbons. Neverthe less, three of four our newly synthesized analogues with bridges bearing three hydroxyl groups, namely compounds 6, 8 and 9 exhibited relatively (3 selectivity.
Mu affinity. Affinities toward /z receptor sites of the analogues exhibited bigger diversity. Almost all compounds expressed higher activity than D A D LE or reference "m onom eric" peptide 11. The most active analogue (E) possessed four-carbon spacer with two vicinal hydroxyl groups of Lthreo configuration. It is possible to assume that the very configuration of this compound meets in the best m anner for the stereochemical require ments of [i binding site. It is interesting that two analogues of five-membered bridge (compounds 6 and 7) and both of the six-membered bridge (com pounds 10 and F) showed also high // affinities comparable to that of dynorp h in (l-1 3 ) and m or phine. We tentatively postulate that these com pounds (6, 7,10 and F) can act as bivalent opioids, binding not very strongly but simultaneously to two closely situated /u receptor sites. An alterna tive explanation is that after the binding of one pharmacophore to the receptor pocket, the other pharmacophore can interact with a certain domain of the receptor to enhance affinity. In either case the optimum distance for a spacer would be 5 -6 carbons.
Kappa affinity and selectivity. The most im pres sive and consisted results were obtained for affini ties toward x receptor binding sites. All analogues exhibited a few orders higher affinity than DAD LE or tetrapeptide opioids (for example the analogue 11). The compound E appeared to have high affinity comparable to dynorp h in (l-1 3 ) . This analogue represents the first opioid peptide de rived from enkephalin showing a preference for x receptors. The other dimeric analogues possessed about two order lower affinity but displayed an interesting dependence of activity on the length of the spacer. The optimum of activity occurred for four carbon linkers and depended on the bridge configuration. In contrast to conclusions about /j. affinity this dependence cannot be explained on the basis of bivalent ligands interactions. Instead, we assume that during binding to the x receptor site one tetrapeptide ligand appear to be "mes sage" [15, 16] and the rest of the molecule includ ing the second tetrapeptide fragment and espe cially the hydrophilic spacer play the role of the "address". In this context we conclude that the an alogues A and B are "too short" to display a high affinity, whereas the five-and six-membered link ers (compounds 6 -1 0 and F) are "too long". In the optimum activity point of four-carbon linkers the dependence on the configuration of the spacer becomes im portant. Again, the most active and x selective com pound (E) have L-threo con figuration.
The results of the study dem onstrate that the use of hydrophilic spacers creates new possibilities in the modulation of activity and selectivity of opi oid peptide bivalent ligands.
